Intraoperative real-time planning prostate brachytherapy: Pre-treatment prostate volume is no longer an exclusion criterion

Brachytherapy ◽  
2008 ◽  
Vol 7 (2) ◽  
pp. 133
Author(s):  
Stuart Duggleby ◽  
Christine Elwell ◽  
Philip Camilleri ◽  
Richard Bell ◽  
Roger Kunkler ◽  
...  
2008 ◽  
Vol 7 (6) ◽  
pp. 463-469 ◽  
Author(s):  
Bruce L. Jacobs ◽  
Erin P. Gibbons ◽  
Ryan P. Smith ◽  
Sushil Beriwal ◽  
Krishna Komanduri ◽  
...  

The purpose of this study was to evaluate the correlation between real-time intra-operative ultrasound-based dosimetry (USD) and day 0 post-implant CT dosimetry (CTD) 131 Cs permanent prostate brachytherapy. Fifty-two consecutive patients who underwent prostate brachytherapy with 131 Cs were evaluated. Real time operating room planning was performed using VariSeed 7.1 software. Post-needle placement prostate volume was used for real-time planning. Targets for dosimetry were D90 >110%, V100 >90%, V150 <50%, and V200 <20%. The CT scan for post-operative dosimetry was obtained on day 0. The mean values for USD, CTD, and the linear correlation, respectively, were, for D90: 114.0%, 105.61%, and 0.15; for V100: 95.1%, 91.6%, and 0.22; for V150: 51.5%, 46.4%, and 0.40; and for V200: 15.8%, 17.9%, and 0.42. The differences between the mean values for USD and CTD for D90 (p<0.01), V100 (p<0.01), and V150 (p<0.05) were statistically significant. For D90, 30.8% of patients had a >15% difference between USD and CTD and 51.9% of patients had a >10% difference between these values. In contrast, the USD and CTD for V100 were within 5% in 55.8% of patients and within 10% in 86.5% of patients. This study demonstrates a correlation between the mean intra-operative USD and post-implant day 0 CTD values only for V200. Significant variation in D90, V150, and V200 values existed for individual patients between USD and CTD. These results suggest that real-time intra-operative USD does not serve as a surrogate for post-operative CTD, and that post-operative CTD is still necessary.


Brachytherapy ◽  
2019 ◽  
Vol 18 (5) ◽  
pp. 675-682 ◽  
Author(s):  
Heather Halperin ◽  
Michelle Hilts ◽  
Juanita Crook ◽  
Deidre Batchelar ◽  
Steven Tisseverasinghe ◽  
...  

2018 ◽  
Vol 127 ◽  
pp. S1239
Author(s):  
L. Oliver Cañamás ◽  
V. González Pérez ◽  
J.L. Guinot ◽  
C. Bosó ◽  
J.C. Sánchez ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 15563-15563
Author(s):  
E. Bieniek ◽  
H. Ashamalla ◽  
A. Guirguis

15563 Purpose: Prostate brachytherapy (PB) has been linked with increase in prostate volume (PV). This study evaluates post- operative PV changes and the variables that might affect prostate swelling. Methods: Twenty four patients (pts) were analyzed. Twelve were treated with PB only, 8 with external beam radiation (EBRT) prior to implant, and 4 with EBRT after PB. Pre-treatment PSA and Gleason score ranges were 1.9–10.8 and 5–8 respectively. Pre- implant and post-implant day 1, 9, 30, and 60 (PV0, PV1, PV9, PV30, and PV60) measurements were done using computed tomography. Univariate analysis of PV change and the following was done: PV0, number of needles, seeds, and needle insertion attempts, seed activity (0.3 vs 0.5mCi), hormonal ablation therapy, and prior EBRT. Urinary symptoms were assessed using International Prostate Scoring System (IPSS). Results: Ninety six PV measurements were done by a single observer. PV0 ranged from 27.1 to 89.4 cc (mean 48.2). Largest PV was observed on day 1 (40.1–118.7, mean 67.1). Successive PV measurements afterwards continued to decrease. Mean PV values on day 9, 30, and 60 were 58.6, 51.5, and 42.3cc respectively. The differences between PV0 and all successive PV’s were statistically significant. Mean increase in PV1 from PV0 was 18.9±16.8cc (p<0.001), PV0 and PV9 9.7cc, PV0 and PV30 2.6cc. PV60 was smaller than PV0 by an average of 6.6cc. Statistically significant positive correlation was found between PV increase and seed activity (p=0.02) while treatment with EBRT prior to PB was associated with less prostate swelling (p=0.043). Other variables were not significantly correlated with PV changes. Although the mean IPSS score increased from pre-implant value of 9.2 to 13.7 on day 60, the differences between IPSS values were not statistically significant. Conclusions: Maximum prostate size is observed on the first day after implant. Prostate begins to decrease in size between day 1 and day 9 and reaches pre-procedure volume after day 30. Higher seed activity results in greater prostate swelling, while less brachytherapy- induced swelling is observed in patients treated with external radiation prior to implant. Resolution of prostate swelling does not appear to parallel with improvement in urinary symptoms in the first 2 months after implant. No significant financial relationships to disclose.


Brachytherapy ◽  
2018 ◽  
Vol 17 (4) ◽  
pp. S84-S85
Author(s):  
Heather Halperin ◽  
Michelle Hilts ◽  
Deidre Batchelar ◽  
Steven Tisseverasinghe ◽  
Juanita Crook ◽  
...  

2005 ◽  
Vol 76 ◽  
pp. S140
Author(s):  
N. Teixeira ◽  
L. Campos ◽  
P. Carvoeiras ◽  
G. Cunha ◽  
J. Varregoso ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document